Use of Misoprostol for medical abortion: A trial of the acceptability for home use;Enquête d'acceptabilité du Misoprostol à domicile pour interruption volontaire de grossesse par méthode médicamenteuse

Gynecologie Obstetrique et Fertilite

Volumn 32, Issue 1, 2004, Pages 28-33

  Dagousset, I ^a   Fourrier, E ^b   Aubeny E ^c   Taurelle, R ^d  

^a HÔPITAL BROUSSAIS   (France)

^b Paris Descartes University   (France)

^c Cabinet Medical   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Good counseling; Inclusion criteria; Medical abortion; Misoprostol home use; Respect of patients' choice

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HOME CARE; HUMAN; INDUCED ABORTION; PATIENT COUNSELING;

EID: 0842303361     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2003.11.005     Document Type: Article

References (7)

1. Aubeny E. La technique d'IVG médicamenteuse par mifépristone jusqu'à 7 semaines d'aménorrhée en 2002 en France. Genesis. 706:2002;15-19.
2. Bureau A., Dagousset I. L'IVG médicamenteuse. Revue du praticien. 506:2000;1377-1381.
3. Schaff E., Stadalius L., Eisinger S., Franks P. Vaginal misoprostol administered at home after mifepristone for abortion. J Fam Pract. 44:1997;356-360.
4. Elul B., Pearlman E., Sorhaindo A., Simonds W., Wesrhoff C. In depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol. J AM MED Womens Assoc. 55:2000;169-172.
5. Winikoff B., Ellerson C., Elul B., Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol: results of a large multicenter trial in the United states. Arch Fam Med. 352:1998;323.
6. Guengnat J.P., Bangout J., Ellul B., Ellertson C. Mifepristone- misoprostol medical abortion: home administration of misoprostol in Guadeloupe. Contraception. 60:1999;167-172.
7. Sitruck-Ware R. Recommandations médicales pour la sécurité d'utilisation de la mifépristone. Références en gynécologie-obstétrique. 6:1999;329-336.